rss
Gut 2005;54:746-751 doi:10.1136/gut.2004.042143
  • Oesophagus

Prognostic influence of Barrett’s oesophagus and Helicobacter pylori infection on healing of erosive gastro-oesophageal reflux disease (GORD) and symptom resolution in non-erosive GORD: report from the ProGORD study

  1. P Malfertheiner1,
  2. T Lind2,
  3. S Willich3,
  4. M Vieth4,
  5. D Jaspersen5,
  6. J Labenz6,
  7. W Meyer-Sabellek7,
  8. O Junghard2,
  9. M Stolte8
  1. 1Department of Gastroenterology, Hepatology, and Infectious Diseases, Otto-von-Guericke University, Magdeburg, Germany
  2. 2AstraZeneca R&D, Mölndal, Sweden
  3. 3Universitätsklinik Charité, Berlin, Germany
  4. 4Institute of Pathology, Otto-von-Guericke-University, Magdeburg, Germany
  5. 5Klinikum Fulda, Germany
  6. 6Ev-Jung-Stilling-Krankenhaus Siegen, Germany
  7. 7AstraZeneca GmbH, Wedel, Germany
  8. 8Klinikum Bayreuth, Institut für Pathologie, Bayreuth, Germany
  1. Correspondence to:
    Professor P Malfertheiner
    Department of Gastroenterology, Hepatology, and Infectious Diseases, Otto-von-Guericke University, Magdeburg, Germany; peter.malfertheiner{at}medizin.uni-magdeburg.de
  • Accepted 12 July 2004
  • Revised 25 June 2004

Abstract

Background: Adequacy of acid suppression is a critical factor influencing healing in gastro-oesophageal reflux disease (GORD). The European prospective study ProGORD was set up to determine the endoscopic and symptomatic progression of GORD over five years under routine care, after initial acid suppression with esomeprazole. We report on factors influencing endoscopic healing and symptom resolution during the acute treatment phase.

Methods: Patients with symptoms suggestive of GORD underwent endoscopy and biopsies were obtained from the oesophagus for diagnosis of abnormalities, including Barrett’s oesophagus (BO). Data from 6215 patients were included in the “intention to treat” analysis, 3245 diagnosed as having erosive reflux disease (ERD) and 2970 non-erosive reflux disease (NERD). ERD patients were treated with esomeprazole 40 mg for 4–8 weeks for endoscopic healing while NERD patients received 20 mg for 2–4 weeks for resolution of heartburn symptoms.

Results: Endoscopic healing occurred overall in 87.7% of ERD patients although healing was significantly lower in those with more severe oesophagitis (76.9%) and in those with BO (72.4%), particularly in Helicobacter pylori negative BO patients (70.1%). Age, sex, and body mass index appeared to have no significant impact on healing. Complete heartburn resolution was reported by 70.4% of ERD patients and by 64.8% of NERD patients at the last visit. Only H pylori infection had a significant influence on complete heartburn resolution in the NERD group (68.1% and 63.7% for H pylori positive and H pylori negative, respectively; p = 0.03).

Conclusion: The presence of Barrett’s mucosa, as well as severe mucosal damage, exerts a negative impact on healing. H pylori infection had a positive influence on healing in ERD patients with coexistent BO but no influence on those without BO.

Footnotes

  • Conflict of interest: None declared.

This Article

  1. Abstract
  2. Full text
  3. PDF

Services

  1. Email this link to a friend
  2. Alert me when this article is cited
  3. Alert me if a correction is posted
  4. Article Usage Statistics
  5. Similar articles in this journal
  6. Similar articles in Web of Science
  7. Similar articles in PubMed
  8. Add article to my folders
  9. Download to citation manager
  10. Request permissions

Social bookmarking

Latest from Gut Education

Latest from Gut Education

Register for free content


Free sample
 This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of Gut.
View free sample issue >>

Free archive
The full back archive is now available for Gut. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006, back to volume 1 issue 1.
Register to access the free archive >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.